ResearcherShimane UniversityActive in the last 2 years
Keizo Takenaga
Matched on ORCID iD 0000-0002-5341-6742; OpenAlex author ID A5046840239. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 10
2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 6
- Downregulation of sST2, a decoy receptor for interleukin-33, enhances subcutaneous tumor growth in murine pancreatic cancer cells. Last author DOI 10.1002/2211-5463.70099↗
- Obesity reduces the anticancer effect of AdipoRon against orthotopic pancreatic cancer in diet-induced obese mice. Co-author DOI 10.1038/s41598-021-82617-2↗
- Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis. Last author DOI 10.1038/s41419-018-0851-z↗
- HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression. First author DOI 10.18632/oncotarget.17157↗
- Attenuation of reactive oxygen species by antioxidants suppresses hypoxia-induced epithelial-mesenchymal transition and metastasis of pancreatic cancer cells. Last author DOI 10.1007/s10585-012-9519-8↗
- Low expression of nucleus accumbens-associated protein 1 predicts poor prognosis for patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/pin.12020↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Miho Akimoto · 5 shared papers, 2013–2025 · strength 0.74
- Paper Downregulation of sST2, a decoy receptor for interleukin-33, enhances subcutaneous tumor growth in murine pancreatic ca… DOI 10.1002/2211-5463.70099↗
- Paper Obesity reduces the anticancer effect of AdipoRon against orthotopic pancreatic cancer in diet-induced obese mice. DOI 10.1038/s41598-021-82617-2↗
- Paper Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-… DOI 10.1038/s41419-018-0851-z↗
- Hiroki Nagase · 1 shared paper, 2021 · strength 0.19
- Yoshitsugu Tajima · 3 shared papers, 2012–2018 · strength 0.17
- Paper Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-… DOI 10.1038/s41419-018-0851-z↗
- Paper Attenuation of reactive oxygen species by antioxidants suppresses hypoxia-induced epithelial-mesenchymal transition and… DOI 10.1007/s10585-012-9519-8↗
- Paper Low expression of nucleus accumbens-associated protein 1 predicts poor prognosis for patients with pancreatic ductal ad… DOI 10.1111/pin.12020↗
- Yasunari Kawabata · 2 shared papers, 2012–2018 · strength 0.13
- Paper Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-… DOI 10.1038/s41419-018-0851-z↗
- Paper Low expression of nucleus accumbens-associated protein 1 predicts poor prognosis for patients with pancreatic ductal ad… DOI 10.1111/pin.12020↗
- Nanae Harashima · 1 shared paper, 2017 · strength 0.10
- Mamoru Harada · 1 shared paper, 2017 · strength 0.10
- Yoshihide Shimojo · 1 shared paper, 2013 · strength 0.04
- Seiji Yano · 1 shared paper, 2012 · strength 0.03
- Takeshi Urano · 1 shared paper, 2012 · strength 0.03
- Takeshi Nishi · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.